Subscribe


PD breaking news – Pfizer to close Sydney plant

Pfizer to phase out Sydney manufacturing by the end of 2015.

Prizer has just announced the closure of its manufacturing operations in Sydney, with about 140 jobs affected.

The factory produces solid oral dose products – tablets and capsules – in the human and animal health area.

“This has been a difficult decision, and reflects the need to align our global manufacturing capacity with the needs of our business,” said Manufacturing Operations Director, Justin Mathie.

“Pfizer has been reviewing our global manufacturing network and capacity in response to changing global demand as a result of the patent expiry of a number of key medicines,” Mathie added.

“In addition our industry is seeing a trend away from high-volume medicines, to high value but lower volume medicines that target a specific patient population or disease condition,” he said, with this necessitating more flexible manufacturing facilities and a different overall approach.

Pfizer’s Perth facility will continue to manufacture sterile injectables for the domestic and export markets.

The closure has no impact on Pfizer’s commercial operations or the supply of its medicines in Australia.

More information in tomorrow’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 26 Sep 13

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

23 Jan

Guild Update 23 Jan 18 - WITH just over a week to go ...


23 Jan

Dispensary Corner 23 Jan 18 - KEEPING kids who suffer from conditions such ...


23 Jan

NZSMI blasts NZ codeine upschedule - ...


23 Jan

Pharmacy BP clinics - THE role community pharmacies can play in ...


23 Jan

Zantac discount deal - ASPEN Australia is promoting a special "double ...


23 Jan

Not-so-smart thief - A woman has been sentenced in the ...


23 Jan

February epidemic asthma surge - THE National Asthma Council Australia is urging ...


23 Jan

New GSK APAC chief - GSK Consumer Healthcare has appointed Filippo Lanzi ...


23 Jan

Pharmacists and AMR - PHARMACISTS are an "underutilised resource for Antimicrobial ...


23 Jan

Adherence Perx - SYDNEY start-up Perx Health, with the support ...


23 Jan

FDA recall guidance - THE U.S. Food and Drug Administration (FDA) ...


23 Jan

TGA extends tender - THE TGA has extended the lodgement date ...


23 Jan

CMA blasts ‘fringe’ groups - COMPLEMENTARY Medicines Australia (CMA) has criticised Friends ...


23 Jan

Dose Innovations administration - EXTERNAL administrators have been appointed to Brisbane-based ...


22 Jan

Weekly Comment 22 Jan 18 - WELCOME to PD's weekly comment feature. This ...


22 Jan

Dispensary Corner 22 Jan 18 - MEDICINAL marijuana is the subject of several ...


22 Jan

FDA pings Delta Labs - THE US Food and Drug Administration (FDA) ...


22 Jan

S3 ad clarification - THE Therapeutic Goods Administration has stressed that ...


22 Jan

Opioid consultation - OPTIONS for a regulatory response to opioid ...


22 Jan

Metformin recall - APOTEX is recallilng one patch of APO-Metformin ...



Show Pharmacy Daily items by month: